Editorial Policies

Aims and Scope

Russian Medicine (also known as Medical Journal of the Russian Federation and/or Russian medical journal) is intended for physicians of all specialties, healthcare professionals, drug developers and regulators, researchers of scientific, medical and educational organizations.

The journal publishes articles of original studies and reviews primarily covers the practical aspects of diagnosis and treatment of a broad spectrum of diseases, as well as information on the most important and actual theoretical and practical issues of health care and medical science. The journal is multidisciplinary within the medicine and covers a wide range of research topics. One of the key features of the journal is cross-cutting articles addressed to a huge auditory of healthcare professionals and researchers from different fields of medicine and for interdisciplinary teams. Ahead of original studies and reviews the journal provides clinical case reports with severe, rare and difficult for diagnoses diseases. 

The main objective of the journal is to promote the achievements of clinical and basic medicine in the world.

Sections

Original Research Articles

Reviews

Case reports

Historical Article

Short Communications

Lectures

Correspondence

News

Biography

Technical Report

Peer Review Process

All the manuscripts submitted for publication in the 'Medical Journal of the Russian Federation' are objects for obligatory evaluation procedure based on peer-review. The peer-review procedure includes the following steps.

1. General expertise of the manuscripts. Within 5 working days from receipt of the manuscript its initial assessment for compliance with the topic and requirements of the Journal is performed. If any discrepancies with the requirements are found, the author(s) will be notified and given the reasons for the rejection. Articles rejected at this stage are not peer-reviewed.

2. External and internal peer-review. External peer-review: if the manuscript is considered relevant to the topic of the Journal and its requirements, it is sent for peer-review to several external peer-reviewers. Internal peer-review is performed by the editor-in-chief, deputy editor-in-chief, editorial board members and science editor.
2.1. The decision on assignment of an external peer-reviewers is made by the editor-in-chief or deputy editor-in-chief.
2.2. External peer-review is performed by recognized experts of the relevant field. Peer-reviewers shold report the scientific, financial or any other relationship with the potential authors (they stay unknown for peer-reviewers) and editors of the journal. Peer-review performed on a voluntary and gratuitous basis.
2.3. The manuscript is sent to external reviewers without mentioning authors and their organizations ("double blind" peer-review).
2.4. Peer-reviewers are informed that manuscripts sent to them are the property of authors and are classified as confidential information. Peer-reviewers must refrain from illegal use (including copying) of the materials sent to them for peer-review.
2.5. Within 14 days from receipt of the manuscript peer-reviewers should render a reasoned opinion on the possibility of its publication in the present form, and present any claims about the manuscript in writing.

The peer-review should highlight the consistency of the article content with the topic stated in the title, the consistency of the article with the modern achievements of science and theoretical knowledge, evaluating language, style, arrangement of the material, clarity and informativeness of tables, charts, figures and completeness and correctness of literature citations, and advantages and disadvantages of the article.  The peer-reviewer also should indicate any amendments that should be made by the author.

Peer-reviewer's possible conclusion:

• the article can be published and does not require revision;
• the article can be published after minor revision by authors;
• the article should be revised and pass thrue an additional round of peer-review;
• the article cannot be published owing to poor quality, inconsistency with the requirements of article design or topic of the journal, ethical violations, signs of falsification of results or other reasons.

2.6. In the case of the peer-reviewers and the editor-in-chief approving publication of the manuscript in the journal, the author(s) will be notified via e-mail that the manuscript is being prepared for publication.
2.7. If the peer-review indicates that corrections to the manuscript are need, the manuscript is returned to the author(s) for revision with the peer-reviews attached and a request to take into account the peer-reviewers’ comments when preparing a revised version of the manuscript. Author(s) must provide responses to all the peer-reviewers’ questions, comments and suggestions. In the case of a disagreement with a peer-reviewer's opinion, the author(s) should clearly justify their point of view. The author(s) responses to peer-reviews must be submitted to the editor within 4 weeks from receipt of the peer-reviews. In the case of absence of a response from the author(s) to a peer-review after this time, the manuscript is considered to have been withdrawn by the author(s). Manuscripts revised by author(s) and the responses to a peer-review are sent to peer-reviewers for evaluation.
2.8. The text of a negative peer-review is sent to the author(s) via e-mail for information.

3. Evaluation by the editorial board is performed for articles which are being prepared for publication in the next issue of the journal. Editorial Board meetings are held once every 2 months. The editorial board approves the list of articles to be published in the current issue of the Journal. The editorial board has the right to reject externally peer-reviewed articles or to send an article for additional external peer-review. The decision of the editorial board is registered in the record of the meeting.
4. Final decision on the possibility of manuscript publication is made by the editor-in-chief or deputy editor-in-chief. All manuscripts that receive the approval of the editor-in-chief or deputy editor-in-chief, are sent for copyediting, translation, layout editing, proofreading and publication. The editors reserve the right to edit (including reduction) submitted articles and their titles.
5. Before publication the layout of the article is sent to corresponding author in *.pdf format by email to proofread for misprints in the text, tables, and figures. Within 48 hours sending the author this e-mail, the author is to send a response to the Journal editor. An authors’ nonresponse is interpreted as acceptance of the sent version of the article.
6. Reviews are kept in the editorial office for five years.
7. The editors send the author(s) of submitted manuscripts copies of reviews or a reasoned rejection, and also assure to send copies of reviews to the Ministry of Education and Science of the Russian Federation upon receiving a relevant request.

8. Manuscripts will be rejected if:

• they are not designed in accordance with the requirements of the Journal, and if authors refuse to revise the manuscript;
• the authors do not follow the reviewer’s and editor’s constructive instructions or do not meet them with counterarguments.

Rejected articles can be re-submitted to the editor after they have been revised by the author(s). They are treated as a new submission according to the standard procedure.

Peer-review quality control

The Editorial Board constantly monitors the quality of peer-review using the Russian version of the Review Quality Instrument questionnaire (Version 3.2), van Rooyen S., Black N., Godlee F. J Clin Epidemiol 1999;52:625-9.

The Editorial Board of the journal expects that the peer-review process will help to:

• prevent publishing poor-quality articles and reject the studies that have not been designed and conducted properly;
• make sure that the data reported in the article are accurate, sufficient, and, where applicable, are presented in compliance with the current international standards CONSORT, STROBE, PRISMA, CARE, STARD (http://www.equator-network.org);
• check whether the previous key studies in the corresponding field of science have been cited;
• make sure that the authors have properly interpreted the data and drawn substantiated conclusions;

and, hence:

• make a decision whether to publish an article or not and offer suggestions to the authors on how to improve the article (where necessary).

Publication Frequency

Medical Journal of the Russian Federation is a bimonthly journal. Regular issues released on February, April, June, August, October, December.

The journal publish peer-reviewed and accepted articles in Online First continuously.

Circulation of print-version: 5000 copies.

Archiving

The journal uses the PKP Preservation Network (PKP PN) to digitally preserve all the published articles. The PKP PN is a part of LOCKSS (Lots of Copies Keep Stuff Safe) program offers decentralized and distributed preservation, seamless perpetual access, and preservation of the authentic original version of the content.

The journal makes archives in Portico for compliance with the MEDLINE preservation requirement for electronic journals. Portico is a community-supported preservation archive that safeguards access to e-journals, e-books, and digital collections.

Also, the journal makes full-text archives on the Russian Science Electronic Library (http://elibrary.ru/) platform.

Author Self-Archiving

The journal is compliant with Green Open Access mode (formerly known as Open Self-Archiving) for articles distribution.

Delayed Open Access

The contents of this journal will be available in an open access format 36 month(s) after an issue is published.

Issue Purchase

Readers without a subscription may still purchase individual issues. The following payment options and fees are available.

Access for an Issue: 370.00 (USD)

You can purchase the access for all articles published in one issue. Access to articles will be provide for an unlimited time.

Access to issue allows you to read, download and print full text (PDF and HTML) of all articles, but does not allow to distribute, copy or reproduce articles materials until the end of the embargo period (3 years) since the publication of the article).

Article Purchase

Readers without a subscription may still purchase individual articles. The following payment options and fees are available.

Access for an Article: 50.00 (USD)

You can purchase the access for the article to read, download and print its fulltext (PDF, HTML). Access to article will be provide for an unlimited time.

Purchased access does not allow to distribute, copy or reproduce article's materials until the end of the embargo period (3 years) since the publication of the article).

Indexing

• Scopus
• Russian Science Citation Index
• Russian Science Citation Index on the Web of Science platform
• "White list" of scientific journals, level 2
• CrossRef
• Google Scholar
• Ulrich’s Periodicals Directory
• WorldCat
• Supreme Attestation Commission of the Russian Federation (Q1)

Publishing Ethics

The Ethic policy of 'Medical Journal of the Russian Federation' is based on recomendations from international commettees:

• ICMJE — The International Committee of MEDICAL JOURNAL EDITORS http://www.icmje.org/
• WAME — The WORLD ASSOCIATION OF MEDICAL EDITORS http://www.wame.org/
• COPE — Committee on Publication Ethics http://publicationethics.org/
• ORI — The office of Research Integrity http://ori.hhs.gov/
• CSE — Council of Science Editors http://www.councilscienceeditors.org/
• EASE — European Association of Science Editors http://www.ease.org.uk/

Reporting standarts

The 'Medical Journal of the Russian Federation' editorial team asks authors of reports of original research to present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable.

Review and professional publication articles should also be accurate and objective, and editorial opinion works should be clearly identified as such.

Data Access and Retention

Authors may be asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data (consistent with the ALPSP-STM Statement on Data and Databases), if practicable, and should in any event be prepared to retain such data for a reasonable time after publication.

Authorship clarified

The 'Medical Journal of the Russian Federation' editorial team assumes all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before the work is submitted.

The Publisher does not prescribe the kinds of contributions that warrant authorship. It is recommended that authors adhere to the guidelines for authorship that are applicable in their specific research field. In absence of specific guidelines it is recommended to adhere to the following guidelines (based on ICMJE guidelines):

All authors whose names appear on the submission:

1. made substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data; or the creation of new software used in the work AND
2. drafted the work or revised it critically for important intellectual content AND
3. approved the version to be published AND
4. agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Anyone who contributed to the research or manuscript preparation, but is not an author, should be acknowledged with their permission.

Submissions by anyone other than one of the authors will not be considered.

Research Ethics and Patient Consent (Statement of Human and Animal Rights)

Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study.

Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.

For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.

Information on informed consent to report individual case reports or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative. Please do not submit the patient’s actual written informed consent with your article, as this in itself breaches the patient’s confidentiality. The journal editorial team requests that you confirm to us, in writing, that you have obtained written informed consent but the written consent itself should be held by the authors/investigators themselves, for example in a patient’s hospital record. The confirmatory letter may be uploaded with your submission as a separate file.

Please also refer to the ICMJE Recommendations for the Protection of Research Participants.

If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript. If the work involves the use of animal or human subjects, the authors should ensure that the manuscript contains a statement that all procedures were performed in compliance with relevant laws and institutional guidelines and that the appropriate institutional committee(s) have approved them. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.

When reporting experiments on animals, authors have to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.

Research involving human embryos, gametes, and stem cells

Manuscripts that report experiments involving the use of human embryos and gametes, human embryonic stem cells and related materials, and clinical applications of stem cells must include confirmation that all experiments were performed in accordance with relevant guidelines and regulations.

The manuscript should include an ethics statement identifying the institutional and/or national research ethics committee (including the name of the ethics committee) approving the experiments and describing any relevant details. Authors should confirm that informed consent was obtained from all recipients and/or donors of cells or tissues, where necessary, and describe the conditions of donation of materials for research, such as human embryos or gametes. Copies of approval and redacted consent documents may be requested by the 'Medical Journal of the Russian Federation' editorial team.

We encourage authors to follow the principles laid out in the 2016 ISSCR Guidelines for Stem Cell Research and Clinical Translation.

In deciding whether to publish papers describing modifications of the human germline, the 'Medical Journal of the Russian Federation' editorial team is guided by safety considerations, compliance with applicable regulations, as well as the status of the societal debate on the implications of such modifications for future generations. 

Use of inclusive language

Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Articles should make no assumptions about the beliefs or commitments of any reader, should contain nothing which might imply that one individual is superior to another on the grounds of race, sex, culture or any other characteristic, and should use inclusive language throughout. Authors should ensure that writing is free from bias, for instance by using 'he or she', 'his/her' instead of 'he' or 'his', and by making use of job titles that are free of stereotyping (e.g. 'chairperson' instead of 'chairman' and 'flight attendant' instead of 'stewardess').

Conflicts of Interest

The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to: patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.

Conflicts include the following:

• Financial — funding and other payments, goods and services received or expected by the authors relating to the subject of the work or from an organization with an interest in the outcome of the work;
• Affiliations — being employed by, on the advisory board for, or a member of an organization with an interest in the outcome of the work;
• Intellectual property — patents or trademarks owned by someone or their organization;
• Personal — friends, family, relationships, and other close personal connections;
• Ideology — beliefs or activism, for example, political or religious, relevant to the work;
• Academic — competitors or someone whose work is critiqued.

For more information on conflicts of interest, see the guidance from the ICMJE and WAME.

Assessment of the reviewer's competence

Evaluation of professional qualities of the reviewer is the exclusive prerogative of the Editorial Board. Attempts by authors to assess the competence of reviewers will lead to rejection of the manuscript.

Funding and Acknowledgement of Sources

Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: https://www.crossref.org/services/funder-registry/  

Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work. Information obtained privately, as in conversation, correspondence, or discussion with third parties, must not be used or reported without explicit, written permission from the source. Information obtained in the course of confidential services, such as refereeing manuscripts or grant applications, must not be used without the explicit written permission of the author of the work involved in these services.

Plagiarism

Plagiarism takes many forms, from passing off another paper as the author(s) own paper, to copying or paraphrasing substantial parts of another(s) paper (without attribution), to claiming results from research conducted by others. Plagiarism in all its forms constitutes unethical publishing behavior and is unacceptable. Only original works are acceptable for publication in 'Medical Journal of the Russian Federation'. The journal does not allow any forms of plagiarism. Authors must not use the words, figures, or ideas of others without attribution. All sources must be cited at 'Medical Journal of the Russian Federation' take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. All the submitted articles are evaluated with plagiarism-checking software (Antiplagiat). Where an article, for example, is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgment, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to:

• publishing an erratum or corrigendum (correction);
• retracting the article;
• taking up the matter with the head of department or dean of the author’s institution and/or relevant academic bodies or societies;
• or taking appropriate legal action.

Also you can see ORI Avoiding Plagiarism, Self-plagiarism, and Other Questionable Writing Practices: A Guide to Ethical Writing

Duplicate Submission and Redundant Publication

'Medical Journal of the Russian Federation' consider only original content, i.e. articles that have not been previously published, including in a language other than English. Articles based on content previously made public only on a preprint server, institutional repository, or in a thesis will be considered.

Manuscripts submitted to 'Medical Journal of the Russian Federation' must not be submitted elsewhere while under consideration and must be withdrawn before being submitted elsewhere. Authors whose articles are found to have been simultaneously submitted elsewhere may incur sanctions.

If authors have used their own previously published work, or work that is currently under review, as the basis for a submitted manuscript, they must cite the previous articles and indicate how their submitted manuscript differs from their previous work. Reuse of the authors’ own words outside the Methods should be attributed or quoted in the text. Reuse of the authors’ own figures or substantial amounts of wording may require permission from the copyright holder and the authors are responsible for obtaining this.

'Medical Journal of the Russian Federation' will consider extended versions of articles published at conferences provided this is declared in the cover letter, the previous version is clearly cited and discussed, there is significant new content, and any necessary permissions are obtained.

Redundant publication, the inappropriate division of study outcomes into more than one article (also known as salami slicing), may result in rejection or a request to merge submitted manuscripts, and the correction of published articles. Duplicate publication of the same, or a very similar, article may result in the retraction of the later article and the authors may incur sanctions.

Citation Manipulation

Authors whose submitted manuscripts are found to include citations whose primary purpose is to increase the number of citations to a given author’s work, or to articles published in a particular journal, may incur sanctions.

Editors and reviewers must not ask authors to include references merely to increase citations to their own or an associate’s work, to the journal, or to another journal they are associated with.

Fundamental errors in published works, Corrections and Retractions

When an author discovers a significant error or inaccuracy in his/her own published work, it is the authors obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper.

If the editor or the publisher learn from a third party that a published work contains a significant error, it is the obligation of the author to promptly retract or correct the paper or provide evidence to the editor of the correctness of the original paper.

When errors are identified in published articles, the publisher will consider what action is required and may consult the editors and the authors’ institution(s). 

Errors by the authors may be corrected by a corrigendum, and errors by the publisher — by an erratum (see more).

If there are errors that significantly affect the conclusions or there is evidence of misconduct, this may require retraction or an expression of concern following the COPE Retraction Guidelines. All authors will be asked to agree to the content of the appropriate notice. 

The journal use the CrossMark technology (by Crossref) to work with Corrections, Retractions and Editorial expressions of concern for Please, see the details on the CrossMark Policy.

Sanctions

If 'Medical Journal of the Russian Federation' editorial team become aware of breaches of our publication ethics policies, the following sanctions may be applied:

• Rejection of the manuscript and any other manuscripts submitted by the author(s).
• Not allowing submission for 1–3 years.
• Prohibition from acting as an editor or reviewer.

The journal editorial team may apply additional sanctions for severe ethical violations.

Adverticement and reprint policy

Our advertising policy is consistent with the principles mentioned in the Recommendations on Publication Ethics Policies for Medical Journals which issued by the World Association of Medical Editors (WAME).

http://www.wame.org/recommendations-on-publication-ethics-policie

1. The 'Medical Journal of the Russian Federation' generate revenue from advertising for the Publisher (Eco-Vector), which creates a potential conflict of interest. To avoid this, editors’ decisions do not depend on the cost of advertising or producing reprints. Advertisers and sponsors have no influence over the editor’s decisions, regardless of the terms of advertising or other agreements.
2. All advertisements are subject to the approval of the Eco-Vector’s staff, which reserves the right to reject or cancel any advertisement at any time.
3. The functions of editors and advertising managers in Eco-Vector’s journals are separate.
4. In Eco-Vector’s journals professional (physician-directed) publications and web sites, the intentional placement of advertising adjacent to articles discussing the company or product that is the subject of the advertisement is prohibited. Advertising content must be distinguished from editorial and other materials so that the difference between them is obvious.
5. Eco-Vector will not publish “advertorial” content, and sponsored supplements must be clearly indicated as such. If a supplement did not undergo peer review or underwent a peer review-process different from the rest of the journal that should be explicitly stated.
6. All Eco-Vector’s journals have the right to refuse any advertisement that, in its sole discretion, is incompatible with its mission or inconsistent with the values of members, the publication/web site or the organization as a whole, and to stop accepting any advertisement previously accepted. Advertisements are subject to review by the editors and others at the Eco-Vector’s journals. In no case shall separate agreements with Eco-Vector’s journals or its subsidiaries supersede this policy.
7. Once an advertisement has been deployed online, it will be withdrawn from the journal site at any time if the Editor(s)-in-Chief or Eco-Vector’s staff request its removal.
8. Advertising for the following categories is prohibited:
   
   • Alcohol
   • Tobacco
   • Weapons, firearms, ammunition
   • Fireworks
   • Gambling and lottery
   • Pornography or related themes
   • Political and religious advertisements
   • Advertisements that claim to have a “miracle” cure or method
   • Advertisements that make unsubstantiated health claims for the products advertised
   • Advertisements directed at children
9. Advertisements may not be deceptive or misleading, and must be verifiable. Advertisements should clearly identify the advertiser and the product or service being offered. Exaggerated or extravagantly worded copy will not be allowed. Advertisements will not be accepted if they appear to be indecent or offensive in either text or artwork, or if they relate to content of a personal, racial, ethnic, sexual orientation, or religious nature.
10. All advertisements are accepted and published by Eco-Vector on the warranty of the advertisement agency and advertiser that both are authorized to publish the entire contents and subject matter of the advertisement.
11. In consideration of publication of an advertisement, the advertiser and the advertisement agency, jointly and severally, agree to indemnify and hold harmless Eco-Vector, its officers, agents and employees against expenses (including legal fees) and losses resulting from the publication of the contents of the advertisement, including, without limitation, claims or suits for libel, violation of privacy, copyright infringement, or plagiarism.
12. Any references to Eco-Vector or its products or services in advertisements, promotional material, or merchandising by the advertiser or agency is subject to Eco-Vector’s written approval for such use.
13. All advertisements for drug-specific campaigns must comply with the relevant Russian legislation that regulates advertising. Advertisers should make available to Eco-Vector the marketing authorization and summary of product characteristics when submitting their advertisement. In the case of drug advertisements, proprietary names of pharmaceutical products must be accompanied by the chemical, generic, or official name; the quantity of all active substances must be stated along with the recommended dosage. Each page of an advertisement for a prescription-only medicine should be clearly labeled as intended for health professionals.
14. Advertisements for products not approved by the FDA or the Ministry of Health of Russian Federation that make any kind of health claims must carry the following disclaimer: “These statements have not been evaluated by the Food and Drug Administration and/or the Ministry of Health of Russian Federation. This product is not intended to diagnose, treat, cure or prevent any disease.”
15. While Eco-Vector’s journals welcomes and encourages information-rich advertising, advertisements, advertising icons and advertiser logos must be clearly distinguishable from editorial content and may require special labeling to distinguish them as such. All advertisements must clearly and prominently identify the advertiser by trademark or signature.
16. Reprints should be published only in the form in which they were originally published in the journal (including subsequent corrections), so there should be no additions or changes in them.
17. Publisher is not responsible for incidental or consequential damage for errors in displaying or printing an advertisement.
18. Advertisements may not imply endorsement by the Eco-Vector’s journals or its publications/web sites except as may be provided for under a separate agreement — in which case advertising must be pre-approved to ensure adherence to the letter and spirit of that separate agreement.
19. The full rules for any market research or promotion associated with an advertisement must be displayed in the advertisement or available via a prominent link.
20. The following online advertising formats are prohibited:
    
    • Pop-ups and floating advertisements.
    • Advertisements that collect personally identifiable information from visitors without their knowledge or permission.
    • Advertisements that extend across or down the page without the visitor having clicked or rolled-over the advertisement.
    • Advertisements that send visitors to another site without the visitor having clicked the advertisement.

Eco-Vector’s journals published advertising policies are not exhaustive and are subject to change at any time without notice.

We partner with third-party advertising companies to serve ads and/or collect certain information when you visit our website. These companies may use cookies or web beacons to collect non-personally identifiable information [not including your name, address, email address or telephone number] during your visit to this website to help show advertisements on other websites also likely to be of interest to you.

For contact with the Advertisement department of the Publisher, please, follow the link https://eco-vector.com/

---